<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
05.04.2020 15:33:00

Should You Buy Gilead Sciences Stock Right Now?

Thousands of stocks have plunged during the coronavirus-fueled market downturn. Gilead Sciences (NASDAQ: GILD) isn't one of them. Shares of the big biotech have instead jumped 20% so far this year, putting Gilead in an elite group of stocks in positive territory in 2020.But should you buy Gilead Sciences stock right now after its solid year-to-date gains? Allow me to try to talk you out of it -- before I attempt to convince you that investing in the biotech is a smart idea.Image source: Getty Images.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

(Anzeige)Passende emittierte Barrier Reverse Convertibles

Basiswert Valor Fälligkeitstag Maximale Rendite p.a.
Gilead Sciences Inc. / Johnson & Johnson / Pfizer Inc. 39255387 05.08.2020 7.04 %

Analysen zu Gilead Sciences Inc.mehr Analysen

15.03.19 Gilead Sciences Outperform BMO Capital Markets
03.01.19 Gilead Sciences Outperform Oppenheimer & Co. Inc.
26.10.18 Gilead Sciences overweight Barclays Capital
01.10.18 Gilead Sciences Overweight Cantor Fitzgerald
26.07.18 Gilead Sciences Neutral Robert W. Baird & Co. Incorporated

Eintrag hinzufügen

Aktien Top Flop

UBS Group 10.46
4.24 %
CS Group 8.78
4.10 %
Swiss Life Hldg 350.00
2.19 %
Adecco Group 46.17
2.15 %
Swiss Re 67.54
2.02 %
Swisscom 489.60
-0.99 %
Givaudan 3’387.00
-0.99 %
Lonza Grp 479.20
-1.36 %
Roche Hldg G 338.45
-1.68 %
Sika 169.10
-4.92 %
Ruhige Woche bahnt sich an | BX Swiss TV

Aktien in diesem Artikel

Gilead Sciences Inc. 66.00 3.77% Gilead Sciences Inc.

Finanzen.net News

pagehit